Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Mayo Clinic Proceedings|October 5, 2020
Ensuring Patient Protections When Tapering Opioids: Consensus Panel RecommendationsEdward C Covington, Charles E Argoff, Jane C Ballantyne, et al.
Neurosurgery|December 29, 2020
Neuromodulation for Chronic Pelvic Pain: A Single-Institution Experience With a Collaborative TeamCheyanne Bridger, Tarun Prabhala, Rachael Dawson, et al.
Pain|June 12, 2018
Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2-The Patient Assessment for Low Back Pain-Impacts (PAL-I)Donald M Bushnell, Steven I Blum, Hiltrud Liedgens, et al.
Neuromodulation : Journal of the International Neuromodulation Society|June 11, 2016
The Effects of Mechanical and Thermal Stimuli on Local Field Potentials and Single Unit Activity in Parkinson's Disease PatientsAbigail Belasen, Youngwon Youn, Lucy Gee, et al.
Pain Medicine (Malden, Mass.)|December 6, 2017
Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus RecommendationsCharles E Argoff, Daniel P Alford, Jeffrey Fudin, et al.
The Journal of Headache and Pain|November 28, 2025
Real-world effectiveness of eptinezumab in chronic migraine-increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fogCharles Argoff, Fawad A Khan, Steven P Herzog, et al.
Pain|February 13, 2019
SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back painJohn Markman, Jeffrey Gudin, Richard Rauck, et al.
Spine|April 14, 2009
Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain SocietyRoger Chou, John D Loeser, Douglas K Owens, et al.
Pain Medicine (Malden, Mass.)|March 25, 2017
Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back PainAbhilasha Ramasamy, Mona L Martin, Steven I Blum, et al.
Pain Medicine (Malden, Mass.)|July 31, 2019
Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS)Jeffrey Gudin, Richard Rauck, Charles Argoff, et al.
Pageof 7